NeurAxis (NRXS) 2025 Conference May 29, 2025 09:30 AM ET Speaker0 Hello, everyone, and thank you all for joining us during the Lithium Partners Spring twenty twenty five Investor Conference. Our next presentation is from Neuraxis. My name is Ben Shamsian, vice president of Lithium Partners. And today, we welcome Brian Karako, CEO, who'll be taking us through a slide presentation followed by a q and a discussion afterwards. Neuraxis trades under the ticker NRXS. Now let's get started. Brian, welcome, and I'l ...

GE Vernova (GEV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this the energy business spun off from General Electric have returned +30.8%, compared to the Zacks S&P 500 composite's +6.7% change. During this period, the Zacks Alternative Energy - Other industry, which GE Vernova falls in, has gained 17%. The key question now is: Wh ...

Core Viewpoint - Goldman Sachs analyst Noah Poponak downgraded Booz Allen Hamilton from Neutral to Sell, lowering the price forecast from $108 to $94, citing limited revenue and earnings growth in the medium term and ongoing valuation risks [1]. Group 1: Revenue and Earnings Outlook - Medium-term revenue growth is now expected to be closer to flat due to pressure on federal civilian spending and shifting priorities within the U.S. Department of Defense [2]. - Organic revenue growth for Booz Allen Hamilton is anticipated to be flat for the next few years, which may take time for the stock to absorb after its previous strong growth [4]. Group 2: Contracting and Margins - The analyst highlights a shift toward more outcomes-based and fixed-price contracting in the sector, raising concerns about increased risk for contractors and potential pressure on margins [4]. - Federal civilian agency budgets are under pressure, with other government spending areas taking priority, which may impact Booz Allen Hamilton's performance [3]. Group 3: Market Reaction - Booz Allen Hamilton shares closed down by 4.70% to $104.66 following the downgrade [5].

Core Viewpoint - Semtech Corporation (SMTC) reported strong first-quarter fiscal 2026 earnings, with non-GAAP earnings of 38 cents per share matching the Zacks Consensus Estimate and revenues of $251.1 million exceeding expectations, indicating robust growth across all end markets, particularly in data centers [1][3][10]. Financial Performance - Non-GAAP earnings of 38 cents per share showed a significant improvement from 6 cents in the year-ago quarter, exceeding management's guidance of 37 cents [1][2]. - Revenues of $251.1 million surpassed the Zacks Consensus Estimate by 0.44% and increased by 22% year over year [3][10]. - Non-GAAP gross margin expanded to 53.5%, up 370 basis points year over year, while non-GAAP operating income surged 88.9% to $47.6 million [7]. Revenue Breakdown - Infrastructure market sales reached $72.8 million, accounting for 29% of net sales, with a year-over-year growth of 30% driven by data center demand [4]. - Industrial market sales were $142.8 million, representing 56.9% of net sales, up 24% year over year [4]. - High-end consumer market sales totaled $35.4 million, a 3% increase year over year, supported by strong design-in momentum for SurgeSwitch [5]. Product Line Performance - Signal Integrity sales were $73.5 million, up 26.1% year over year, making up 29.3% of net sales [6]. - Analog Mixed Signal & Wireless sales reached $90.6 million, a 20.3% increase year over year, accounting for 36.1% of net sales [6]. - IoT System and Connectivity sales were $86.9 million, reflecting a 19.9% year-over-year growth, comprising 34.6% of net sales [6]. Future Guidance - For Q2, Semtech expects net sales of $256 million (+/- $5 million), indicating a year-over-year rise of 18.5% [10]. - The company anticipates non-GAAP earnings of 40 cents (+/- 3 cents) per share, representing a year-over-year increase of 254.6% [12]. - Non-GAAP gross margin is expected to be around 53% (+/- 50 bps) for the upcoming quarter [11].

Shares of Willis Towers Watson Public Limited Company (WTW) have gained 24.7% in the past year, outperforming the Finance sector and the Zacks S&P 500 composite’s growth of 17.4% and 9.3%, respectively. Shares of WTW have underperformed the industry’s growth of 26.5% in the same time frame.The insurer has a market capitalization of $30.99 billion. The average volume of shares traded in the last three months was 0.6 million.WTW shares are trading below the 200-day moving average, indicating a bullish trend.W ...

Core Viewpoint - Astronics Corporation's stock price has increased by 100% year-to-date, driven by strong business performance and the resolution of legacy patent disputes [1][2] Company Performance - The company supplies parts and components to the aerospace industry, experiencing thriving business conditions with a shift towards profitability and sustained double-digit revenue growth [2] - Q1 2025 highlights include a 700 basis points top-line outperformance, with gross and operating margins expanding by over 500 basis points, leading to adjusted earnings increasing by over 400% [3] Financial Guidance - Astronics reaffirmed its 2025 outlook, projecting approximately 6% revenue growth at the midpoint range, with expectations for improved guidance in subsequent quarters [4] Balance Sheet Strength - The balance sheet shows increased cash and assets, reduced debt, and improved shareholder equity by over 4% in Q1, indicating robust operational capacity [5][6] Market Activity - Institutional investors own about 57% of the stock and are actively buying, with buying activity outpacing selling by more than four times [6][7] - Short interest was nearly 10% at the end of April, which could amplify the positive market impact from institutional buying [7] Stock Price Forecast - The 12-month stock price forecast is set at $21.00, indicating a potential downside of 33.80% from the current price [8][9] Upcoming Catalysts - The next significant event is the Q2 earnings release scheduled for early August, with analysts forecasting about 5% sequential growth and margin strength [10]

Investor Presentation FIRST QUARTER | FISCAL YEAR 2026 Forward Looking Statements This presentation includes express or implied statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events or our future financial or operational performance and may contain projections of our future results o ...

Core Insights - Senstar Technologies Corporation reported strong financial results for the first quarter of 2025, highlighting double-digit revenue growth and significant improvements in gross and EBITDA margins [2][3][5]. Financial Performance - Revenue for Q1 2025 was $8.4 million, a 12.5% increase from $7.5 million in Q1 2024 [3][8]. - Gross profit reached $5.7 million, representing a gross margin of 67.2%, up from 59.6% in the previous year [3][8]. - Operating income was $1.0 million compared to an operating loss of $73,000 in the same quarter last year [5][8]. - Net income for Q1 2025 was $1.0 million, or $0.04 per share, compared to a net loss of $0.7 million, or ($0.03) per share, in Q1 2024 [5][8]. - EBITDA for the first quarter was $1.2 million, a significant increase from $114,000 in Q1 2024 [6][8]. Cost Management - Operating expenses were $4.6 million, a slight increase of 2% from $4.5 million in Q1 2024, primarily due to targeted marketing and selling expenses [4][8]. - The increase in gross margin was attributed to a balanced product mix, cost optimization, and efficient cost control [3][8]. Cash Position - As of March 31, 2025, cash and cash equivalents, along with short-term bank deposits, totaled $22 million, up from $20.6 million at the end of 2024 [6][8]. Market Position - The company experienced strong demand across its core verticals, including Corrections, Energy, and Logistics, and noted growing global interest in its MultiSensor solution [2].

Core Viewpoint - UnitedHealth Group has experienced a significant stock decline, with a 5.71% drop on May 21, 2025, bringing its stock price to $302.98, marking a 42% decrease year-to-date and 43% over the last 12 months, primarily due to disappointing Q1 results and reduced full-year guidance [1][9] Peer Comparison - Compared to competitors, UnitedHealth's decline is notable; Cigna increased by 4% in 2025 and 5.8% over the previous year, while Molina Healthcare saw a 2.4% year-to-date increase. Humana, like UnitedHealth, faced a drop of over 45% due to Medicare Advantage pressures [2] Valuation - UnitedHealth is trading at a price-to-sales ratio of 0.7, a price-to-earnings ratio of 12.4, and a price-to-free cash flow ratio of 9.6, all significantly lower than the S&P 500 averages, indicating a potential entry opportunity for long-term investors [3] Growth - The company has shown solid revenue growth, with an average annual growth rate of 11.3% over the last three years and a recent revenue increase of 8.1% from $372 billion to $400 billion [4] Profitability - UnitedHealth's profitability is a concern, with an operating income of $33 billion and a net margin of 5.4%, indicating inefficiencies in converting revenue into profit [5] Financial Stability - The balance sheet remains robust, with $81 billion in debt against a market capitalization of $378 billion, resulting in a moderate debt-to-equity ratio of 29.6% and strong liquidity with $29 billion in cash [6] Downturn Resilience - Historically, UnitedHealth has shown resilience during market downturns, with less severe declines compared to the S&P 500 during crises, indicating its capability to recover from systemic shocks [8] Conclusion - Despite legitimate concerns regarding stock decline and profitability, ongoing revenue growth, a solid balance sheet, and historical resilience suggest that the selloff may be excessive, presenting a compelling recovery narrative for long-term investors [9]

Core Viewpoint - Flanigan's Enterprises, Inc. has experienced significant stock appreciation following its latest quarterly results, outperforming the S&P 500 Index during the same period [1] Financial Performance - For the quarter ended March 29, 2025, Flanigan's reported total revenues of $53.6 million, an 11.6% increase from $48.1 million a year ago [2] - Net income attributable to BDL stockholders rose 38.5% to $2.7 million from $1.9 million, translating to earnings of $1.45 per diluted share, up 39.4% from $1.04 in the prior-year quarter [2] - Restaurant food and bar sales increased to $40.8 million, a 9.9% rise from $37.1 million, while package store sales surged 18.8% to $12.1 million from $10.1 million [2] Profitability and Margins - Gross profit from restaurant and bar operations increased 10.2% to $27.4 million, while package store gross profit rose 27.7% to $3.4 million [3] - The gross profit margin for restaurant food and bar sales increased to 67.23% from 67.09% year over year, and for package store sales, it rose to 28.06% from 26.11% [3] Pricing Strategy - Flanigan's implemented targeted menu price increases in late 2024 and early 2025 to counter inflationary pressures, with bar prices raised by approximately 5.63% in August 2024 and food prices by 4.14% in November 2024 [4] Operational Insights - The restaurant operations generated $4.7 million in operating income, up 18.6% from $4 million a year earlier, while the package store segment posted $1.3 million, up 67.1% from $0.8 million [5] - A new company-owned restaurant opened in Hollywood, FL in March 2024 contributed to revenue growth [6] Comparable Sales Growth - Comparable weekly restaurant food sales rose 5.9%, with company-owned restaurants seeing an 8.1% increase [7] - Weekly average same-store package liquor store sales increased 18.9% year over year [7] Future Outlook - Flanigan's anticipates continued revenue growth throughout fiscal 2025, driven by the full-year impact of price adjustments and stable demand [8] Cost Management - Payroll costs increased 8.1% to $16.2 million, but as a percentage of revenue, they declined to 30.2% from 31.1% year over year, indicating improved labor efficiency [10] - Overall costs as a percentage of total revenues decreased from 94.4% to 93.2% due to cost containment strategies [11] Capital Expenditures and Liquidity - Flanigan's invested $1.73 million in capital expenditures during the 26 weeks ended March 29, 2025, and entered a purchase agreement for baby back ribs valued at approximately $7.8 million for 2025 [13] - The company reported a healthy liquidity position with $22.9 million in cash as of March 29, 2025, up from $21.4 million as of September 28, 2024 [14]